|
|
Example
: Measurement of effect duration of a bronchodilatating association
(pirbuterol - ipratropium bromide) (AP) using nocturnal asthma
monitoring (4 puffs preventive dose at bedtime).
The study was performed in 10 patients experiencing brittle asthma.
Capnographic monitoring during two double-blind consecutive nights
after AP or Placebo (PCB).
Continuous assessment of S3 indice (alveolar plateau slope,
n<0.5%/sec).
Difference is significant up to 6th hour.
|
|